@enoughhealth: One RCT out of UC San Diego (June 2026) found semaglutide was associated with slower epigenetic aging marker accumulation in humans — not mice, not a lab dish. Gallup's 2026 data also shows U.S. adult obesity declining alongside rising GLP-1 prescriptions. One trial. Real caveats. The longevity science is early and investigational — but researchers are paying attention. For adults 18+ — educational content only, not medical advice. Follow for the actual science. #GLP1 #Semaglutide #Longevity #BiologicalAging #EpigeneticClock #HealthScience #EnoughHealth

enoughhealth

Open In TikTok:

Region: US

Wednesday 02 September 2026 20:30:26 GMT